Regulatory

FDA approves vismodegib for basal cell cancers

Washington — The Food and Drug Administration has approved the groundbreaking, first-in-class drug Erivedge (vismodegib, Genentech) to treat adult patients with advanced and metastatic basal cell cancers. » More

FDA OKs ingenol mebutate for AK treatment

Washington — The Food and Drug Administration has approved Picato gel (ingenol mebutate, Leo Pharma) as a treatment for actinic keratoses on the face, scalp, trunk and extremities. » More

ETIOLOGY

No infection, environmental cause found for Morgellons

Atlanta — The Centers for Disease Control and Prevention has released a study that finds no evidence linking Morgellons disease to an infection or environmental cause. » More

FYI ...

2 million

Estimated number of Americans affected by basal cell carcinoma each year

Source: Skin Cancer Foundation

COSMECEUTICALS

Pine bark extract improves skin aging signs

Dusseldorf, Germany — Clinical trial results suggest that natural supplement Pycnogenol (Horphag Research), an antioxidant plant extract from the bark of the French maritime pine tree, improves skin hydration and elasticity in women. » More

Find Resources to Help Manage Plaque Psoriasis Effectively

SKIN CANCER

Ban baseball caps, Aussie cancer council urges

Sydney — The Cancer Council of New South Wales says baseball caps should be banned from schools because they place children at an unacceptable risk of developing skin cancers later in life, the Sydney Morning Herald reports. » More

New Job Opportunities

Center for Dermatology Care		Cynthia Dreyer MD
Dr. Ira Schlesinger		David A High MD
Dermatology Associates of Lancaster		Goldman Dermatology
Madison Skin & Laser		Manhattan Dermatology
Mark Burnett MD		Minden Dermatology
Ochsner Health System

Tools

•	Information Technology
•	Meetings & Events
•	Practice Management
•	Resource Centers

Digital Edition

•	View current edition

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.